# US 2012/0232545 A1 · System and method for endometrial ablation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232545 A1
- Document ID: US20120232545A1
- Status: Published application
- Kind: A1
- Application number: 13/416,791
- Filed: 2012-03-09
- Published: 2012-09-13
- Earliest claimed: 2011-03-11
- Assignees: Minerva Surgical, Inc.
- Inventors: Csaba Truckai; Robin Bek; Akos Toth
- Web page: https://patentgrep.com/patent/US20120232545A1

## CPC

- A61B 18/14: Probes or electrodes therefor
- A61B 18/042: {using additional gas becoming plasma}
- A61B 18/1485: {having a short rigid shaft for accessing the inner body through natural openings}
- A61B 2017/4216: {Operations on uterus, e.g. endometrium}
- A61B 2018/0022: {Balloons}
- A61B 2018/00559: {Female reproductive organs}
- A61B 2018/00577: {Ablation}
- A61B 2018/00767: {Voltage}
- A61B 2018/147: {Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO2) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.

## Claims

### Claim 1

A medical method for ablating tissue, comprising:
creating a negative pressure in a neutral gas in a fluid-tight chamber of a dielectric positioned adjacent to targeted tissue;
applying RF energy to ignite and maintain a plasma in the negative pressure neutral gas;
adjusting the negative pressure toward an ambient pressure while maintaining the plasma, wherein the dielectric delivers energy to the targeted tissue.

### Claim 2 (depends on 1)

The method of claim 1 wherein creating the negative pressure is initiated at between −0.25 psig and −10 psig.

### Claim 3 (depends on 1)

The method of claim 1 wherein creating the negative pressure is initiated at between −0.5 psig and −5 psig.

### Claim 4 (depends on 1)

The method of claim 1 further comprising terminating the negative pressure after initiating RF application.

### Claim 5 (depends on 4)

The method of claim 4 wherein terminating the negative pressure occurs between 0.1 and 10 seconds after initiating RF application.

### Claim 6 (depends on 1)

The method of claim 1 wherein the applying step applies at least 150 volts.

### Claim 7 (depends on 6)

The method of claim 6 wherein applying at least 150 volts occurs for less than 10 seconds, less than 5 seconds or less than 2 seconds.

### Claim 8 (depends on 1)

The method of claim 1 wherein the step includes a voltage spike of at least 150 volts to initiate plasma followed by a plasma-maintaining voltage to maintain the plasma over a treatment interval.

### Claim 9 (depends on 1)

The method of claim 1 wherein the adjusting step includes adjusting the pressure to a positive pressure.

### Claim 10 (depends on 9)

The method of claim 9 wherein the positive pressure is at least +0.1 psig.

### Claim 11 (depends on 9)

The method of claim 9 wherein the positive pressure is in the range of +0.5 psig to 10 psig.

### Claim 12 (depends on 1)

The method of claim 1 wherein the creating step includes an initial stage that creates a negative pressure is below −5 psig in the fluid-tight chamber of the dielectric positioned outside the patient's body to facilitate trans-cervical introduction of the dielectric.

### Claim 13

An endometrial ablation device, comprising:
a probe working end having an expandable dielectric with an ablation surface configured for expansion in a patient's uterine cavity;
a negative pressure source operatively coupled to a interior chamber of the expandable dielectric;
a positive pressure source operatively coupled to the interior chamber for introducing a gas therein; and
at least one electrode carried by the working end.

### Claim 14 (depends on 13)

The endometrial ablation device of claim 13 further comprising a controller capable of differentially controlling the positive and negative pressure sources to provide a pressure in the interior chamber between −10 psig and +10 psig.

### Claim 15 (depends on 13)

The endometrial ablation device of claim 13 wherein the positive pressure source to provides an inflow of a neutral gas.

### Claim 16 (depends on 15)

The endometrial ablation device of claim 15 wherein the neutral gas is argon.

### Claim 17 (depends on 14)

The endometrial ablation device of claim 14 further comprising an RF source operatively coupled to the at least one electrode and wherein the controller is capable of controlling voltage between 10 volts and 300 volts.
